Related Experiment Video

Updated: Oct 6, 2025

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

18.4K

The Challenge of Melanoma Chemoprevention

Craig A Elmets1,2,3,4, Andrzej Slominski2,3,4, Mohammad Athar5,3

  • 1Department of Dermatology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. celmets@uabmc.edu.

Cancer Prevention Research (Philadelphia, Pa.)
|January 14, 2022
PubMed

Insights

Low-dose aspirin did not prevent melanoma progression from dysplastic nevi in a clinical trial. Further research is needed for effective melanoma chemoprevention agents.

Area of Science:

  • Oncology
  • Cancer Prevention
  • Dermatology

Background:

  • Melanoma is a difficult-to-treat cancer originating from melanocytes.
  • There's a critical need for agents to prevent melanoma development from dysplastic nevi.
  • Cyclooxygenase-2 (COX-2) inhibitors like aspirin and NSAIDs are explored for chemoprevention due to their anti-cancer properties.

Purpose of the Study:

  • To evaluate the efficacy of low-dose aspirin in preventing the progression of premalignant dysplastic nevi to melanoma.
  • To assess the impact of aspirin on biomarkers associated with melanoma development.

Main Methods:

  • A clinical trial was conducted to investigate the effect of low-dose aspirin.
  • Biomarkers related to the progression of dysplastic nevi to melanoma were monitored.

Main Results:

  • The clinical trial did not demonstrate a significant effect of aspirin on the studied biomarkers.
  • Aspirin did not inhibit the progression of premalignant dysplastic nevi to melanoma in this trial.

Conclusions:

  • Low-dose aspirin is not effective in preventing melanoma progression from dysplastic nevi based on the evaluated biomarkers.
  • Further clinical trials exploring different biomarkers, NSAIDs, or other chemopreventive agents are warranted for melanoma risk reduction.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.0K
A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.0K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
712
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
546